Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
7.87
4.44
56.42%
Share Warrants & Outstandings
Total Reserve
33.10
9.73
23.37
240.18%
Shareholder's Funds
45.42
17.60
27.82
158.07%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
2.47
-0.09
-3.64%
Secured Loans
2.38
1.00
1.38
138.00%
Unsecured Loans
0.00
1.47
-1.47
-100.00%
Deferred Tax Assets / Liabilities
-4.37
0.79
-5.16
-653.16%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.68
-0.56
-82.35%
Total Non-Current Liabilities
-1.87
3.94
-5.81
-147.46%
Current Liabilities
Trade Payables
5.59
12.54
-6.95
-55.42%
Other Current Liabilities
1.74
7.60
-5.86
-77.11%
Short Term Borrowings
5.02
28.55
-23.53
-82.42%
Short Term Provisions
0.01
1.74
-1.73
-99.43%
Total Current Liabilities
12.37
50.43
-38.06
-75.47%
Total Liabilities
55.92
71.96
-16.04
-22.29%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
18.86
8.32
44.11%
Less: Accumulated Depreciation
8.48
10.45
-1.97
-18.85%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
8.41
10.29
122.35%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
0.00
10.14
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.01
0.04
400.00%
Long Term Loans & Advances
2.12
0.07
2.05
2,928.57%
Other Non Current Assets
0.00
0.28
-0.28
-100.00%
Total Non-Current Assets
31.01
8.77
22.24
253.59%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
30.84
-22.62
-73.35%
Sundry Debtors
13.54
21.92
-8.38
-38.23%
Cash and Bank
0.73
1.54
-0.81
-52.60%
Other Current Assets
0.41
0.57
-0.16
-28.07%
Short Term Loans and Advances
2.00
8.32
-6.32
-75.96%
Total Current Assets
24.91
63.19
-38.28
-60.58%
Net Current Assets (Including Current Investments)
12.54
12.76
-0.22
-1.72%
Total Current Assets Excluding Current Investments
24.91
63.19
-38.28
-60.58%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
71.96
-16.04
-22.29%
Contingent Liabilities
0.00
0.17
-0.17
-100.00%
Total Debt
7.40
31.03
-23.63
-76.15%
Book Value per share (adjusted)
7.38
22.37
-14.99
-67.01%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
